BioCentury
ARTICLE | Company News

INC Research, Kendle deal

May 9, 2011 7:00 AM UTC

INC Research will acquire fellow CRO Kendle for $15.25 per share, or about $232 million in cash. The price is a 61% premium to Kendle's close of $9.50 on May 4, before the deal was announced. The comp...